CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a novel technology platform for drug discovery targeting G protein-coupled receptors (GPCRs). By utilizing advanced fluorescent sensors, the platform aims to provide more accurate detection and classification of drug candidates, enhancing the efficiency of the drug development process…
This project by a consortium of academic labs and small biotech companies concerns a new key innovation for the development of drugs targeting G protein-coupled receptors (GPCRs). GPCRs are the most important class of therapeutic targets, both for current drugs and those under development, covering about a third of the €1.2 trillion pharmaceutical market.
Recent research has revealed that GPCRs do not function as simple on/off switches but instead can adopt multiple conformations leading to comp…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, SANTIAGO DE COMPOSTELA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Czechia, Praha 1
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Czechia, Prague
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
